202 related articles for article (PubMed ID: 10818257)
1. Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.
Rupniak NM; Carlson EC; Harrison T; Oates B; Seward E; Owen S; de Felipe C; Hunt S; Wheeldon A
Neuropharmacology; 2000 Jun; 39(8):1413-21. PubMed ID: 10818257
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.
Rupniak NM; Carlson EJ; Webb JK; Harrison T; Porsolt RD; Roux S; de Felipe C; Hunt SP; Oates B; Wheeldon A
Behav Pharmacol; 2001 Nov; 12(6-7):497-508. PubMed ID: 11742144
[TBL] [Abstract][Full Text] [Related]
3. Intra-amygdala injection of the substance P [NK(1) receptor] antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs.
Boyce S; Smith D; Carlson E; Hewson L; Rigby M; O'Donnell R; Harrison T; Rupniak NM
Neuropharmacology; 2001 Jul; 41(1):130-7. PubMed ID: 11445193
[TBL] [Abstract][Full Text] [Related]
4. LY303870, a centrally active neurokinin-1 antagonist with a long duration of action.
Iyengar S; Hipskind PA; Gehlert DR; Schober D; Lobb KL; Nixon JA; Helton DR; Kallman MJ; Boucher S; Couture R; Li DL; Simmons RM
J Pharmacol Exp Ther; 1997 Feb; 280(2):774-85. PubMed ID: 9023291
[TBL] [Abstract][Full Text] [Related]
5. Tonic immobility in guinea pigs: a behavioural response for detecting an anxiolytic-like effect?
Olsen CK; Hogg S; Lapiz MD
Behav Pharmacol; 2002 Jul; 13(4):261-9. PubMed ID: 12218506
[TBL] [Abstract][Full Text] [Related]
6. Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups.
Kehne JH; Coverdale S; McCloskey TC; Hoffman DC; Cassella JV
Neuropharmacology; 2000 Jun; 39(8):1357-67. PubMed ID: 10818252
[TBL] [Abstract][Full Text] [Related]
7. Reduction of guinea pig pup isolation calls by anxiolytic and antidepressant drugs.
Molewijk HE; Hartog K; van der Poel AM; Mos J; Olivier B
Psychopharmacology (Berl); 1996 Nov; 128(1):31-8. PubMed ID: 8944403
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the functional blockade of rat substance P (NK1) receptors by GR205171, RP67580, SR140333 and NKP-608.
Rupniak NM; Carlson EJ; Shepheard S; Bentley G; Williams AR; Hill A; Swain C; Mills SG; Di Salvo J; Kilburn R; Cascieri MA; Kurtz MM; Tsao KL; Gould SL; Chicchi GG
Neuropharmacology; 2003 Aug; 45(2):231-41. PubMed ID: 12842129
[TBL] [Abstract][Full Text] [Related]
9. NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats.
Vassout A; Veenstra S; Hauser K; Ofner S; Brugger F; Schilling W; Gentsch C
Regul Pept; 2000 Dec; 96(1-2):7-16. PubMed ID: 11102646
[TBL] [Abstract][Full Text] [Related]
10. Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models.
Louis C; Stemmelin J; Boulay D; Bergis O; Cohen C; Griebel G
Pharmacol Biochem Behav; 2008 Mar; 89(1):36-45. PubMed ID: 18045668
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyzine prevents isolation-induced vocalization in guinea pig pups: comparison with chlorpheniramine and immepip.
Lamberty Y; Gower AJ
Pharmacol Biochem Behav; 2004 Sep; 79(1):119-24. PubMed ID: 15388291
[TBL] [Abstract][Full Text] [Related]
12. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
Tauer U; Zhao Y; Hunt SP; Culman J
Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ
Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239
[TBL] [Abstract][Full Text] [Related]
14. S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.
Millan MJ; Dekeyne A; Gobert A; Mannoury la Cour C; Brocco M; Rivet JM; Di Cara B; Lejeune F; Cremers TI; Flik G; de Jong TR; Olivier B; de Nanteuil G
Eur Neuropsychopharmacol; 2010 Sep; 20(9):599-621. PubMed ID: 20483567
[TBL] [Abstract][Full Text] [Related]
15. Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.
Brocco M; Dekeyne A; Mannoury la Cour C; Touzard M; Girardon S; Veiga S; de Nanteuil G; deJong TR; Olivier B; Millan MJ
Eur Neuropsychopharmacol; 2008 Oct; 18(10):729-50. PubMed ID: 18657401
[TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
[TBL] [Abstract][Full Text] [Related]
17. Stress-induced vocalisation in adult animals. A valid model of anxiety?
Sánchez C
Eur J Pharmacol; 2003 Feb; 463(1-3):133-43. PubMed ID: 12600706
[TBL] [Abstract][Full Text] [Related]
18. Distribution of Fos-like immunoreactivity in guinea-pig brain following administration of the neurokinin-1 receptor agonist, [SAR9,MET(O2)11]substance P.
Yip J; Chahl LA
Neuroscience; 1999; 94(2):663-73. PubMed ID: 10579226
[TBL] [Abstract][Full Text] [Related]
19. Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801.
Bert L; Rodier D; Bougault I; Allouard N; Le-Fur G; Soubrié P; Steinberg R
Synapse; 2002 Jan; 43(1):62-9. PubMed ID: 11746734
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
